EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
Acquired resistance inevitably limits the curative effects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which represent the classical paradigm of molecular-targeted therapies in non-small-cell lung cancer (NSCLC). How to break such a bottleneck becomes a pressing probl...
Saved in:
Published in | Frontiers in oncology Vol. 9; p. 1044 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
11.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!